Early Detection of SARS-CoV-2 and other Infections in Solid Organ Transplant Recipients and Household Members using Wearable Devices
|New!||Wearables Study to detect SARS-CoV-2 and other post-transplant infections|
iGeneTRAiN is currently combining genetic data from these subjects with the aim of detecting genes and specific variants underpinning rejection. A number of the iGeneTRAiN studies are also working on markers from urine, blood and tissue to predict rejection weeks to months before it manifests clinically.
The International Genetics & Translational Research in Transplantation Network (iGeneTRAiN) DNA, biospecimens and outcomes data from over 56,000 transplant recipients/donors across over a dozen countries, with the ultimate goal of using these genetic and other data-sets to better understand transplant complications and thus improve treatment for transplant patients.